Corcept Therapeutics, Inc. (CORT)
35.71
+0.43
(+1.22%)
USD |
NASDAQ |
Mar 04, 16:00
36.00
+0.29
(+0.81%)
After-Hours: 20:00
Corcept Therapeutics Cash from Investing (TTM) : 69.76M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Axsome Therapeutics, Inc. | -0.48M |
| United Therapeutics Corp. | -551.30M |
| Harrow, Inc. | -38.29M |
| Ultragenyx Pharmaceutical, Inc. | 236.00M |
| Amneal Pharmaceuticals, Inc. | -112.26M |